8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 15, 2010

MMRGLOBAL, INC.
(Exact Name of Registrant as Specified in Charter)

DELAWARE	000-51134	33-0892797
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
468 NORTH CAMDEN DRIVE, 2nd FLOOR BEVERLY HILLS, CA		90210
(Address of Principal Executive Offices)		(Zip Code)

(310) 476-7002
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01   Entry into a Material Definitive Agreement.

Investment Agreement Addendum

On June 18, 2010, MMRGlobal, Inc. (the "Company") f/k/a MMR Information Systems, Inc. and Dutchess Opportunity Fund II, LP f/k/a Dutchess Equity Fund, LP (the "Investor) entered into an Addendum (the "Addendum") to the Investment Agreement (the "Investment Agreement") and the Registration Rights Agreement (the "Registration Rights Agreement" previously entered into by the Company and Investor on September 15, 2009. The Addendum, among other things, (i) provides that the Investor shall commit to purchase up to $10,000,000 of the Company's common stock, (ii) amends the definition of purchase price to ninety-four percent (94%) of the average of two lowest daily volume weighted average price during the pricing period, and (iii) removes any reference to the previous "Minimum Acceptable Price" or "Best Bid".

Pursuant to the Investment Agreement, as amended by the Addendum, the Company may draw on an equity line facility (the "Equity Line") from time to time, as and when it determines appropriate in accordance with the terms and conditions of the Investment Agreement. A maximum of 100 million shares may be issued under the Equity Line, at per share prices set at ninety-four percent (94%) of the average of two lowest daily volume weighted average price ("VWAP") of the Company's common stock during the five consecutive trading day period beginning on the trading day immediately following the date of delivery of the applicable put notice (such five-day period, the "Pricing Period").

The maximum amount that the Company is entitled to put in any one notice ("Put") remains the greater of (i) 200% of the average daily volume (U.S. market only) of the common stock for the three (3) trading days prior to the date of delivery of the applicable put notice, multiplied by the average of the closing prices for such trading days or (ii) $150,000. There are put restrictions applied on days between the put notice date and the closing date with respect to that particular Put. During such time, the Company shall not be entitled to deliver another put notice.

The Investor will not be obligated to purchase shares if the Investor's total number of shares beneficially held would exceed 4.99% of the number of shares of the Company's common stock as determined in accordance with Rule 13d-1 of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement (as further explained below) to cover the resale of the shares.

The Investment Agreement further provides that each of the Investor and the Company is entitled to customary indemnification from the other for any losses or liabilities it suffers as a result of any breach by the other under any provisions of the Investment Agreement or Registration Rights Agreement, or as a result of any lawsuit brought by a third-party arising out of or resulting from the other party's execution, delivery, performance or enforcement of the Investment Agreement or the Registration Rights Agreement.

The Investment Agreement also contains representations and warranties of each of the Company and the Investor. The assertions embodied in those representations and warranties were made for purposes of the Investment Agreement and are subject to qualifications and limitations agreed to by the respective parties in connection with negotiating the terms of the Investment Agreement. In addition, certain representations and warranties, which were made as of a specific date, may be subject to a contractual standard of materiality different from what a stockholder or investor might view as material, or may have been used for purposes of allocating risk between the respective parties rather than establishing matters as facts. Investors should read the Investment Agreement together with the

other information concerning the Company that the Company publicly files in reports and statements with the Securities and Exchange Commission (the "SEC").

Pursuant to the terms of the Registration Rights Agreement, as amended by the Addendum, the Company is obligated to file one or more registration statements with the SEC to register the resale by the Investor of shares of common stock issued or issuable under the Investment Agreement and is further obligated to use all commercially reasonable efforts to have the initial registration statement declared effective by the SEC within 180 days after the effective date of the Addendum.

In connection with the original preparation of the Investment Agreement and the Registration Rights Agreement, but not the Addendum, the Company paid Dutchess a document preparation fee in the amount of $5,000, and issued Dutchess 230,800 shares of common stock, which equaled $30,000 worth of common stock based on the closing sales price of the Company's common stock on August 13, 2009, the execution date of the non-binding term sheet with Dutchess.

The foregoing description of each of the Investment Agreement and the Registration Rights Agreement is qualified in its entirety by reference to the full texts of the Investment Agreement and the Registration Rights Agreement, which are filed as Exhibits 10.1 and 10.2, respectively, to the Current Report on Form 8-K filed on September 15, 2009, and incorporated herein by reference.

The foregoing description of the Addendum does not purport to be complete and is qualified in its entirety by reference to the full text of the Addendum, a copy of which is filed with this Current Report on Form 8-K as Exhibit 10.1, and is incorporated herein by reference.

Richard Teich Employment Agreement

On June 15, 2010, the Company appointed Richard Teich, 56, as the Company's Executive Vice-President. Mr. Teich has been employed by MyMedicalRecords.com (now MMRGlobal) since the Company's inception in 2005. His responsibilities with the Company have included management of product development and website technical development for the Company's suite of products. He also has been involved in key account sales as well creating marketing programs to support MMRGlobal's products and services. Teich has extensive experience working with technology companies, gained while working for advertising agencies in Los Angeles and New York. Pursuant to such appointment, the Company and its subsidiary and Mr. Teich entered into an employment agreement (the "Teich Employment Agreement"). The term of the Teich Employment Agreement expires on June 15, 2012, but may be extended automatically for successive additional one-year periods at the expiration of the then-current term unless written notice of non-extension is provided to Mr. Teich with at least 60 days prior notice to the expiration of each term. Mr. Teich will be paid a monthly base salary of $15,000 and an initial signing bonus of $3,000. The Teich Employment Agreement also provides certain severance benefits in the event that the Teich Employment Agreement is terminated without cause. In such event, Mr. Teich's monthly salary shall continue to be paid for two (2) months, if such termination occurs within the first year of employment; for three (3) months, if such termination occurs between the first year and the last day of the second year of employment; and for six (6) months, if such termination occurs after the last day of the second year of employment.

In connection with Mr. Teich's appointment as Executive Vice President, the Board of Directors granted Mr. Teich an option to purchase up to 1,000,000 shares of the Company's common stock (the "Teich Option") under the Company's 2001 Equity Incentive Plan. The Teich Option vests quarterly in equal installment over a one year period, and has a per share exercise price of $0.18 per share, which equals the closing price per share of the Company's common stock on the date of the grant. The Teich Option has a life of ten (10) years.

The preceding discussion of the material terms of the Teich Employment Agreement is qualified in its entirety by reference to the entire text of the Teich Employment Agreement, filed as Exhibit 10.2 with this Current Report on Form 8-K, and incorporated herein by this reference.

Rafael Salazar Employment Agreement

Also on June 15, 2010, the Company appointed Rafael ("Ralph") Salazar, age 64, as its Vice President, Communications and Carrier Relations. Over the last five years, Mr. Salazar has worked as a District Manager, Carrier Relations and Services Technology for AT&T as well as a being a Telecommunications Consultant to several companies including Landmark Real Estate, Coldwell Banker, and Rancho Real Estate Group among others. Mr. Salazar has been in the telecommunications, operations, administration, international telephony and management business since 1966. In addition to his above described work, prior to joining MMR, Mr. Salazar held technology and management leadership positions with Pac Bell, NBC, RCA, three Olympic Committees, European Broadcasting Union International for World Cup Soccer events, SmarTalk Teleservices and AT&T, where he dealt with carriers in Europe, Asia and the Americas. Salazar's involvement with the Olympics, SmarTalk and AT&T has provided him ample experience in working in procurement and operations with international carriers. Mr. Salazar concentrated his education curriculum in the fields of electronic engineering, radio and television broadcasting, computer technology, wireless communications, finance and business administration. Mr. Salazar has taught multiple customer service seminars and technology training courses. Pursuant to such appointment, the Company and its subsidiary and Mr. Salazar entered into an employment agreement (the "Salazar Employment Agreement"). The term of the Salazar Employment Agreement expires on June 15, 2012, but may be extended automatically for successive additional one-year periods at the expiration of the then-current term unless written notice of non-extension is provided to Mr. Salazar with at least 60 days prior notice to the expiration of each term. Mr. Salazar will be paid an annual base salary of $80,000, with annual base salary increases of not less than five percent (5%). The Salazar Employment Agreement also provides certain severance benefits in the event that the Salazar Employment Agreement is terminated by the Company without cause. In such event, Mr. Salazar's monthly salary shall continue to be paid for two (2) months, if such termination occurs after the first two years of employment, and for three (3) months, if such termination occurs after two years of employment.

The preceding discussion of the material terms of the Salazar Employment Agreement is qualified in its entirety by reference to the entire text of the Salazar Employment Agreement, filed as Exhibit 10.3 with this Current Report on Form 8-K and incorporated herein by this reference.

Ingrid Safranek Employment Agreement Amendment

On June 15, 2010, the Board approved an amendment to the employment agreement by and between the Company, its subsidiary and Ingrid Safranek, the Company's and its subsidiary's Vice President and Chief Financial Officer (the "Safranek Amendment"). Pursuant to the terms of the Safranek Amendment, Ms. Safranek's base salary was increased to $120,000 per year and shall be entitled to annual base salary increase of not less than five percent (5%). In addition, Ms. Safranek also received certain benefits, including health insurance coverage and reimbursement, four (4) weeks vacation per year, and other benefits and perquisites generally available to the executive officers of the Company and its subsidiary.

Also on June 15, 2010, the Board granted Ms. Safranek an option to purchase up to 1,000,000 shares of the Company's common stock (the "Safranek Option") pursuant to the 2001 Equity Incentive Plan. The Safranek Option vests quarterly in equal installment over a one year period, and has a per share exercise price of $0.18 per share, which equals the closing price per share of the Company's common stock on the date of the grant. The Safranek Option has a life of ten (10) years.

The preceding discussion of the material terms of the Safranek Amendment is qualified in its entirety by reference to the entire text of the Safranek Amendment, filed as Exhibit 10.4 with this Current Report on Form 8-K and incorporated herein by this reference.

Item 4.02   Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

(a) In August 29, 2009, the Company filed a 10-Q/A and an explanatory news release, but did not file a Current Report on Form 8-K at the same time. Accordingly, this Current Report on Form 8-K relates solely to that first quarter 2009 filing. It does not amend any filing and does not restate any filing. The Financial statements currently on file on Form 10Q/A for the first quarter ended March 31, 2009 are still reliable. The purposes of this filing is because the Company has been informed by the Securities and Exchange Commission (the "Commission") that it should have also filed an 8-K on August 29, 2009, and the Company is making this filing solely to fulfill the Commission's request

Background.

On August 27, 2009, management and the Audit Committee of the Board of Directors (the "Audit Committee") of MMRGlobal, Inc. (the "Company") determined that the financial statements as of and for the three months ended March 31, 2009 previously filed by the Company with the Securities and Exchange Commission (the "Commission") on its Quarterly Report on Form 10-Q contained an error in the Company's previously issued financial statements. On the same date as its discovery of the error, the Audit Committee decided to file, and actually did file, an amended Quarterly Report on Form 10-Q/A reflecting a correction of that error. No new or additional non-reliance or restatement in previously issued financials is being reported herein.

The circumstances surrounding the error initially arose upon the merger between the Company and Favrille, Inc. on January 27, 2009. The Audit Committee determined that at the time of the Company's merger with and into Favrille, Inc. (the "Merger"), and as a result of the Merger, the Company had inadvertently exceeded the number of shares it was authorized to issue. On August 27, 2009, the date of the filing of the Company's Form 10-Q/A, the Audit Committee determined that such error should result in a restatement of the Company's financials for the quarter ended March 31, 2009.

Although the Audit Committee determined to restate its financials, the Audit Committee did not at any time believe that it was required to do so. The Audit Committee discussed with the Company's independent auditors the circumstances surrounding the error disclosed herein and determined that there were several options available to the Company other than restatement to remedy the error. One option available to the Company would have been for the Company to engage the services of additional accounting consultants with the particular experience to deal with such issues as involved in the merger. Another option available to the Company would have been for the Company to solicit the advice of the Commission in soliciting a comment. The Company's independent auditors did not require the Company to restate its financial statements given the existence of these alternatives. However, the Audit Committee determined at that time that restating the Company's financial statements, although not mandatory, would be the easiest solution for stockholders, investors and the public to understand. Other solutions may have required a longer time to implement resulting in more confusion and compounding the error in subsequent quarterly reports. Given the Company's impending deadline for the filing of the Company's Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2009, the Company wanted to have consistent financial statements without confusing explanations. Thus, immediately restating the financial statements for the prior quarter made more sense from an implementation perspective and the desire to not have to revist the issue in subsequent quarters.

Item 5.02   Appointment of Certain Officers.

The information required under Item 5.02 is incorporated by reference from the information provided in Item 1.01 in this Current Report on Form 8-K.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 15, 2010, the stockholders of the Company approved an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter Amendment") to change the Company's name from MMR Information Systems, Inc. to MMRGlobal, Inc. The Company submitted the Charter Amendment to the Delaware Secretary of State's office on June 16, 2010, and the Charter Amendment became effective on the same day.

The Company's common stock will continue to trade on the OTCBB. The Company has requested a new trading symbol for its common stock, but such symbol has not been approved as of the date of this Current Report. Until the Company receives such new trading symbol, if any, the Company common stock will continue to trade under the symbol "MMRF." In connection with the Company's name change, the Company has requested that its common stock be assigned a new CUSIP number.

A copy of the Charter Amendment (as filed with the Delaware Secretary of State) is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 5.07   Submission of Matters to a Vote of Security Holders.

On June 15, 2010, the Company held its 2010 annual meeting of stockholders (the "Annual Meeting"). The Company solicited proxies for the Annual Meeting pursuant to Regulation 14A under the Securities Exchange Act of 1934. As of the April 19, 2010 record date for the annual meeting, there were 204,260,891 shares of the Company's common stock eligible to vote. At the Annual Meeting of stockholders, the holders of 112,061,982 shares of the Company's common stock were represented in person or by proxy, which constituted a quorum.

Proposal 1: The Company's Class I nominees for election to the Board of Directors as listed in the Company's proxy statement were each elected to a three-year term, with the results of the voting as follows:

Nominee	Votes For	Votes Withheld	Broker Non-Votes
Douglas H. Helm	85,563,502	385,592	26,112,888
Jack Zwissig	85,556,702	392,392	26,112,888

Proposal 2: The Company also requested shareholder ratification of the selection of Rose Snyder & Jacobs ("RSJ") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2010. As indicated below, the proposal to ratify the appointment of RSJ was approved:

Description	Votes For	Votes Against	Abstentions	Broker Non-Votes
Ratification of the appointment of RSJ	111,988,745	26,839	46,398	0

Proposal 3: Approval of amendment to the Company's 2001 Equity Incentive Plan (the "Plan") to increase the authorized shares by 15,000,000 shares and to fix the number of authorized shares at 27,000,000 shares:

Description	Votes For	Votes Against	Abstentions	Broker Non-Votes
Approval of Amendment to Company's 2001 Equity Incentive Plan	85,237,253	545,211	166,630	26,112,888

Proposal 4: The Company also requested shareholder approval to amend Article I of the Company's Amended and Restated Certificate of Incorporation to change its name from MMR Information Systems, Inc. to MMRGlobal, Inc.

Description	Votes For	Votes Against	Abstentions	Broker Non-Votes
Approval of Amendment to Article I of the Company's Amended and Restated Certificate of Incorporation to change the Company name to MMRGlobal, Inc.	111,986,572	47,111	28,299	0

As indicated in the above tables, the proposals to elect two (2) director nominees, ratify the appointment of RSJ, approve the amendment to the Plan and approve the amendment to Article I of the Company's Amended and Restated Certificate of Incorporation were approved.

Item 7.01   Regulation FD Disclosure.

On June 15, 2010, Mr. Lorsch, the Company's Chairman, President, and Chief Executive Officer, answered questions provided by stockholders attending the Annual Meeting. A copy of the press release disclosing the questions and answers is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01   Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number	Description
3.1	Amendment to the Amended and Restated Certificate of Incorporation.
10.1	Addendum, dated June 17, 2010, to the Investment Agreement and the Registration Agreement, both dated September 15, 2009, by and between MMR Information Systems, Inc. and Dutchess Opportunity Fund II, LP f/k/a Dutchess Equity Fund, LP.
10.2	Employment Agreement, dated June 15, 2010, by and between the Company and Richard Teich.
10.3	Employment Agreement, dated June 15, 2010, by and between the Company and Rafael Salazar.
10.4	Memorandum of Understanding, dated as of June 15, 2010, by and between the Company and Ingrid Safranek.
99.1	Press release issued on June 16, 2010.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MMRGLOBAL, INC.
June 18, 2010	By: /s/ Robert H. Lorsch         Robert H. Lorsch         Chief Executive Officer

EXHIBIT INDEX

Exhibit Number	Description
3.1	Amendment to the Amended and Restated Certificate of Incorporation.      Also provided in PDF format as a courtesy.
10.1	Addendum, dated June 17, 2010, to the Investment Agreement and the Registration Agreement, both dated September 15, 2009, by and between MMR Information Systems, Inc. and Dutchess Opportunity Fund II, LP f/k/a Dutchess Equity Fund, LP.      Also provided in PDF format as a courtesy.
10.2	Employment Agreement, dated June 15, 2010, by and between the Company and Richard Teich.      Also provided in PDF format as a courtesy.
10.3	Employment Agreement, dated June 15, 2010, by and between the Company and Rafael Salazar.      Also provided in PDF format as a courtesy.
10.4	Memorandum of Understanding, dated as of June 15, 2010, by and between the Company and Ingrid Safranek.      Also provided in PDF format as a courtesy.
99.1	Press release issued on June 16, 2010.      Also provided in PDF format as a courtesy.

EX-3.1

EXHIBIT 3.1

CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
MMR INFORMATION SYSTEMS, INC.

MMR Information Systems, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the "Corporation"), hereby certifies that:

FIRST: The name of the Corporation is MMR Information Systems, Inc.

SECOND: The date on which the Certificate of Incorporation of the Corporation was originally filed with the Secretary of State of the State of Delaware is January 21, 2000.

THIRD: The Board of Directors of the Corporation, acting in accordance with the provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions amending its Certificate of Incorporation as follows:

"I.

The name of this corporation is MMRGlobal, Inc."

FOURTH: Thereafter pursuant to a resolution of the Board of Directors, this Certificate of Amendment was submitted to the stockholders of the Corporation for their approval, and was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its Chairman, Chief Executive Officer and President this 15th day of June, 2010.

MMR INFORMATION SYSTEMS, INC.

By: /s/ Robert H. Lorsch
    Robert H. Lorsch
    Chairman, President and Chief
    Executive Officer

EX-10.1

EXHIBIT 10.1

ADDENDUM

This Addendum ("Addendum"), to the Investment Agreement dated September 15, 2009 (the "Investment Agreement") between Dutchess Opportunity Fund, II, LP f/k/a Dutchess Equity Fund, LP, ("Dutchess") and MMR Information Systems, Inc., (the "Company"), and the Registration Rights Agreement dated September 15, 2009 between Dutchess and the Company ("Registration Rights Agreement") is made this 18th day of June, 2010.

WHEREAS, it is in the best interest of both parties to facilitate (the "Facilitation") the amendments in connection with the Investment Agreement and Registration Rights Agreement (collectively, hereinafter referred to as the "Equity Line Transaction Documents").

NOW, THEREFORE, in consideration of the premises and mutual covenants and agreements set forth herein and in reliance upon the representations and warranties contained herein, the parties hereto covenant and agree as follows:

1. Amendment to the Investment Agreement.
1. The Investment Agreement is hereby amended to DELETE in its entirety the definition of Purchase Price and contemporaneously the Investment Agreement is hereby amended to INSERT the following sentence as the amended definition of Purchase Price:

"Purchase Price" shall mean ninety-four percent (94%) of the average of two lowest daily VWAP during the Pricing Period.

2. The Investment Agreement is hereby amended to DELETE in its entirety the definition of Best Bid.
3. The Investment Agreement is hereby amended to DELETE in its entirety the definition of VWAP and contemporaneously the Investment Agreement is hereby amended to INSERT the following sentence as the amended definition of VWAP:

"VWAP" means the volume weighted average price of the Common Stock for such date on the Principal Market on which the Common Stock is then listed or quoted for trading as reported by Bloomberg Financial L.P. or other nationally recognized quotation service.

4. The Investment Agreement is hereby amended to DELETE in its entirety section 2(c) of the Investment Agreement and any reference to the Minimum Acceptable Price.

   Any such reference made in the Investment Agreement to Purchase Price, VWAP, Minimum Acceptable Price or Best Bid, shall refer to the amended sections, as described herein.

5. The first preamble to the Investment Agreement is hereby amended and restated in its entirety to read as follows:

"WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Ten Million dollars ($10,000,000) to purchase the Company's Common Stock, $0.001 par value per share (the "Common Stock");"

6. Section 2(A) is hereby amended and restated in its entirety to read as follows:

   "PURCHASE AND SALE OF COMMON STOCK. Subject to the terms and conditions set forth herein, during the Open Period, the Company may issue and sell to the Investor, and the Investor shall purchase from the Company, up to that number of Shares having an aggregate Purchase Price of Ten Million dollars ($10,000,000)."

7. Section 9(I) is hereby amended and restated in its entirety to read as follows:

   "when the Investor has purchased an aggregate of Ten Million dollars ($10,000,000) in the Common Stock of the Company pursuant to this Agreement; or,"

2. Amendment to the Registration Rights Agreement.
1. The Registration Rights Agreement is hereby amended to DELETE in its entirety the Section 2(b) and contemporaneously the Registration Rights Agreement is hereby amended to INSERT the following section as the amended Section 2(b):

The Company shall use all commercially reasonable efforts to have the initial Registration Statement declared effective by the SEC within one hundred eighty (180) calendar days after the Execution Date.

3. No other terms, rights or provisions of the Equity Line Transaction Documents are or should be considered to have been modified by the terms of this Addendum and each party retains all other rights, obligations, privileges and duties contained in Equity Line Transaction Documents that correspond respectively to the Agreements.

Agreed and Accepted, and duly authorized to sign, on this 18th day of June, 2010

By Dutchess: /s/ Douglas H. Leighton
                             Douglas H. Leighton, Managing Director

By Company: /s/ Robert H. Lorsch
                             Robert H. Lorsch, Chief Executive Officer

EX-10.2 4 exh10-2.htm EMPLOYMENT AGREEMENT, DATED JUNE 15, 2010, BY AND BETWEEN THE COMPANY AND RICHARD TEICH

EXHIBIT 10.2

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this "Agreement"), dated as of June 15, 2010 (the "Effective Date"), is made by MyMedicalRecords, Inc., a Delaware corporation and MMRGlobal a Delaware Corporation ("the Company") and Richard Teich (the "Executive").

WITNESSETH:

WHEREAS, the Company desires to employ the Executive as its Executive Vice President;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby covenant and agree as follows:

1. Employment

The Company hereby agrees to retain the Executive, and the Executive hereby agrees to be employed by the Company, on an at-will basis and subject to the additional terms and conditions of this Agreement.

2. Term

The term of this Agreement (the "Agreement Term") shall commence on the Effective Date and shall expire on June 15, 2012 (the "Initial Term") unless extended or otherwise terminated pursuant to this Agreement (the "Employment Period"). The Agreement Term shall be extended automatically for successive additional one-year periods at the expiration of the then-current term unless written notice of non-extension is provided by the Company to the Executive after appropriate Board resolution at least 60 days prior to the expiration of the Initial Term or such extended term, as the case may be.

3. Responsibilities

The Executive shall provide services as requested by the Company reporting to the Chief Executive Officer ("CEO") unless otherwise directed by the CEO. The Executive's job description and title(s) may be changed the Company. The Executive agrees to devote all time, efforts and skills reasonably necessary to the performance of his duties and responsibilities under this Agreement.

4. Compensation

In consideration of the services rendered by the Executive during the term hereof the Company shall pay Executive the amounts set forth below.

1. Salary. 　 The Company shall pay the Executive, on a semi-monthly basis, a base salary of $15,000 per month (the "Base Salary. The Base Salary shall be subject to a review after six months and then annual reviews, provided that as of each June 1 during the Agreement Term the amount of the Base Salary shall increase by not less than 5% of the then current base salary.
2. Bonus. 　 The Executive shall be paid a signing bonus of $3,000 upon signing of this Agreement.
3. Executive Benefits. 　 The Executive shall also be entitled to (i) health insurance pursuant to the plan made available generally to employees of the Company or reimbursement of one half of the Executive's monthly COBRA payment; (ii) Four (4) weeks' vacation for each 12-month period during the Employment Period; (iii) reasonable travel expenses incurred in connection with her responsibilities; and (iv) such other benefits and

perquisites that are generally made available to senior executives of the Company from time to time. Executive further agrees to be bound by the policies and procedures outlined in the Company's Employee Manual.

4. Indemnification. The Executive shall be provided with any indemnification rights and indemnification insurance coverage on the same basis as are provided to other senior executives of the Company.
5. Reimbursement of Expenses. 　 The Company shall reimburse all reasonable business expenses and disbursements incurred by the Executive in the performance of his duties under this Agreement.
6. Deferred Compensation and Interest. The Company acknowledge that the Executive agrees that it could be necessary to defer certain payments or benefits, and the Company does not intend that Executive relinquish, and Executive does not hereby relinquish, any rights thereto.
7. Termination. 　 In the event that this Agreement is terminated by the Company without Cause (as such term is defined herein), the Company shall continue paying the monthly salary required under Section 4(a) hereof for two (2) months, if such termination occurs within the first year of employment; for three (3) months, if such termination occurs between the first year and the last day of the second year of employment; and for six (6) months, if such termination occurs after the last day of the second year of employment. If this Agreement is terminated by the Company due to Executive's misconduct (including, but not limited to, any act of dishonesty, willful misconduct, fraud or embezzlement) or should the Executive make or attempt to make any unauthorized use or disclosure of material confidential information or trade secrets of the Company or any parent or subsidiary corporation (any of the foregoing, a "Cause"), then the Company shall not be required to continue paying the monthly salary required under Section 4(a) and the Company shall only be required to pay such salary as has been accrued to that date pursuant to the existing agreement for payout of any deferred salaries. For purposes of clarification, a change in title or diminution of responsibilities, regardless of the level of materiality, shall not be considered a termination under the provisions of this Agreement.
5. Miscellaneous
1. Successors and Assigns. 　 This Agreement shall be binding upon and shall inure to the benefit of the Company and the Executive, and their successors and assignees.
2. Entire Agreement. 　 This Agreement sets forth the entire agreement of the Executive and the Company in respect of the subject matter contained herein and supersedes all prior agreements, memoranda of understanding, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by the parties hereto in respect of the subject matter contained herein. Any amendment or modification of this Agreement shall not be binding unless in writing and signed by the Company and the Executive.
3. Severability. 　 In the event that any provision of this Agreement is determined to be invalid or unenforceable, the remaining terms and conditions of this Agreement shall be unaffected and shall remain in full force and effect, and any such determination of invalidity or unenforceability shall not affect the validity or enforceability of any other provision of this Agreement.

4. Notices. 　 All notices which may be necessary or proper for the Company or the Executive to give to the other shall be in writing and shall be delivered by hand or sent by registered or certified mail, return receipt requested and actually received, or by air courier, and shall be deemed given when sent, to the respective persons at the addresses set forth in Annex A (or such other address as any party may provide to the other parties after the date hereof).
5. Governing Law. 　 This Agreement shall be governed by and enforceable in accordance with the laws of the State of California, without giving effect to the principles of conflict of laws thereof.
6. Counterparts. 　 This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same Instrument.
7. No Rules of Construction. 　 No rules of construction are intended by the parties hereto and none shall be employed or used in the interpretation of this Agreement. For all purposes, both parties hereto shall be deemed joint authors hereof.

IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first set forth above.

MyMedicalRecords, Inc.

By: /s/ Robert H. Lorsch
Name: Robert H. Lorsch
Title: Chief Executive Officer

Richard Teich

By: /s/ Richard Teich

EX-10.2

Exhibit 10.2

EX-10.3

EXHIBIT 10.3

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this "Agreement"), dated as of June 15, 2010 (the "Effective Date"), is made by MyMedicalRecords, Inc., a Delaware corporation and MMRGlobal a Delaware Corporation ("the Company") and Rafael Salazar (the "Executive").

WITNESSETH:

WHEREAS, the Company desires to employ the Executive as its Vice President Telecommunications & Carrier Relations;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby covenant and agree as follows:

1. Employment

The Company hereby agrees to retain the Executive, and the Executive hereby agrees to be employed by the Company, on an at-will basis and subject to the additional terms and conditions of this Agreement.

2. Term

The term of this Agreement (the "Agreement Term") shall commence on the Effective Date and shall expire on June 15, 2012 (the "Initial Term") unless extended or otherwise terminated pursuant to this Agreement (the "Employment Period"). The Agreement Term shall be extended automatically for successive additional one-year periods at the expiration of the then-current term unless written notice of non-extension is provided by the Company to the Executive after appropriate Board resolution at least 60 days prior to the expiration of the Initial Term or such extended term, as the case may be.

3. Responsibilities

The Executive shall provide services as requested by the Company reporting to the Chief Executive Officer ("CEO") unless otherwise directed by the CEO. The Executive's job description and title(s) may be changed the Company. The Executive agrees to devote all time, efforts and skills reasonably necessary to the performance of his duties and responsibilities under this Agreement.

4. Compensation

In consideration of the services rendered by the Executive during the term hereof the Company shall pay Executive the amounts set forth below.

1. Salary. 　 The Company shall pay the Executive, on a semi-monthly basis, a base salary of $80,000 per year (the "Base Salary"). The Base Salary shall be subject to an increase as determined by the Board of Directors of the Company from time to time in its sole discretion, provided that as of each June 1 during the Agreement Term the amount of the Base Salary shall increase by not less than 5% of the then current base salary.
2. Bonus. 　 The Compensation Committee of the Company shall annually determine whether or not an additional bonus should be payable to Executive in consideration for services rendered during the prior year.

3. Executive Benefits. 　 The Executive shall also be entitled to (i) health insurance pursuant to the plan made available generally to employees of the Company; (ii) vacation pursuant to the policies of the Company for each 12-month period during the Employment Period; (iii) reasonable travel expenses incurred in connection with her responsibilities; and (iv) such other benefits and perquisites that are generally made available to senior executives the Company from time to time. Executive further agrees to be bound by the policies and procedures outlined in the Company's Employee Manual.
4. Indemnification. The Executive shall be provided with any indemnification rights and indemnification insurance coverage on the same basis as are provided to other senior executives of the Company.
5. Reimbursement of Expenses. 　 The Company shall reimburse all reasonable business expenses and disbursements incurred by the Executive in the performance of his duties under this Agreement.
6. Deferred Compensation and Interest. The Company acknowledge that the Executive agrees that it could be necessary to defer certain payments or benefits, and the Company does not intend that Executive relinquish, and Executive does not hereby relinquish, any rights thereto.
7. Termination. 　 In the event that this Agreement is terminated by the Company without Cause (as such term is defined herein), the Company shall continue paying the monthly salary required under Section 4(a) hereof for two (2) months, if such termination occurs after the last day of the second year of employment; and for three (3) months, if such termination occurs after the last day of the third year of employment. If this Agreement is terminated by the Company due to Executive's misconduct (including, but not limited to, any act of dishonesty, willful misconduct, fraud or embezzlement) or should the Executive make or attempt to make any unauthorized use or disclosure of material confidential information or trade secrets of and the Company or any parent or subsidiary corporation (any of the foregoing, a "Cause"), then the Company shall not be required to continue paying the monthly salary required under Section 4(a) and the Company shall only be required to pay such salary as has been accrued to that date. For purposes of clarification, a change in title or diminution of responsibilities, regardless of the level of materiality, shall not be considered a termination under the provisions of this Agreement.
5. Miscellaneous
1. Successors and Assigns. 　 This Agreement shall be binding upon and shall inure to the benefit of the Company and the Executive, and their successors and assignees.
2. Entire Agreement. 　 This Agreement sets forth the entire agreement of the Executive and the Company in respect of the subject matter contained herein and supersedes all prior agreements, memoranda of understanding, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by the parties hereto in respect of the subject matter contained herein. Any amendment or modification of this Agreement shall not be binding unless in writing and signed by the Company and the Executive.
3. Severability. 　 In the event that any provision of this Agreement is determined to be invalid or unenforceable, the remaining terms and conditions of this Agreement shall be unaffected and shall remain in full force and effect, and any such determination of invalidity or unenforceability shall not affect the validity or enforceability of any other provision of this Agreement.

4. Notices. 　 All notices which may be necessary or proper for the Company or the Executive to give to the other shall be in writing and shall be delivered by hand or sent by registered or certified mail, return receipt requested and actually received, or by air courier, and shall be deemed given when sent, to the respective persons at the addresses set forth in Annex A (or such other address as any party may provide to the other parties after the date hereof).
5. Governing Law. 　 This Agreement shall be governed by and enforceable in accordance with the laws of the State of California, without giving effect to the principles of conflict of laws thereof.
6. Counterparts. 　 This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same Instrument.
7. No Rules of Construction. 　 No rules of construction are intended by the parties hereto and none shall be employed or used in the interpretation of this Agreement. For all purposes, both parties hereto shall be deemed joint authors hereof.

IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first set forth above.

MyMedicalRecords, Inc.

By: /s/ Robert H. Lorsch
Name: Robert H. Lorsch
Title: Chief Executive Officer

Rafael Salazar

By: /s/ Rafael Salazar

EX-10.4

EXHIBIT 10.4

MEMORANDUM OF UNDERSTANDING

June 15, 2010

This is an amendment to the existing Employment Agreement between Ingrid G. Safranek (the "Executive") and MMRGlobal, Inc., a Delaware corporation (formerly known as MMR Information Systems, Inc.), hereby referred to as the "Parent", and MyMedicalRecords, Inc. a Delaware corporation and a wholly-owned subsidiary of Parent ( the "Company") dated January 26, 2010:

1. Clause 4(a) "Salary" shall be amended to read: Effective June 15, 2010, Parent and the Company shall pay the Executive, on a semi-monthly basis, a base salary of $120,000 per year (the "Base Salary"). The Base Salary shall be subject to an increase as determined by the Board of Directors of Parent from time to time in its sole discretion, provided that as of each June 1 during the Agreement Term the amount of the Base Salary shall increase by not less than 5% of the then current base salary.
2. Clause 4(d) "Executive Benefits" shall be amended to read: Effective June 15, 2010, the Executive shall also be entitled to (i) health insurance pursuant to the plan made available generally to employees of Parent and the Company or a monthly reimbursement of what would cost the Company to cover the Executive under the Company's plan if the Executive is covered under their own policy; (ii) Four (4) weeks vacation pursuant to the policies of the Company and Parent for each 12-month period during the Employment Period; (iii) reasonable travel expenses incurred in connection with her responsibilities; and (iv) such other benefits and perquisites that are generally made available to senior executives of Parent and the Company from time to time. Executive further agrees to be bound by the policies and procedures outlined in the Company's and Parent's Employee Manual.
3. Notwithstanding anything in this MOU, nothing supersedes the terms of the Employment Agreement between the Company and Employee dated January 26, 2010 other than clause 4a (Salary) and Clause 4d (Benefits) of the said Employment Agreement.

/s/ Robert H. Lorsch
For MyMedicalRecords, Inc.
Robert H Lorsch
Chairman and CEO /s/ Ingrid Safranek
Employee
Ingrid Safranek

/s/ Robert H. Lorsch
For MMRGlobal, Inc.
Robert H Lorsch
Chairman and CEO

EX-99.1

EXHIBIT 99.1

FOR IMMEDIATE RELEASE

MMR Information Systems Becomes MMRGlobal

CEO Answers Shareholder Questions

LOS ANGELES, CA--(Marketwire - June 16, 2010) - MMR Information Systems, Inc. (OTC.BB: MMRF - News) (www.mymedicalrecords.com), at its June 15 shareholder meeting, announced that it has officially changed its name to MMRGlobal, Inc. to more accurately reflect the Company's business as a worldwide provider of its MyMedicalRecords consumer and professional products for the healthcare industry globally.

Robert H. Lorsch, Chairman and CEO of MMRGlobal, Inc., said, "We are now positioned to do business in more than 100 countries as a result of our contract with Chartis International, our relationship with Unis and Kodak in China, and our targeted expansion into India. Ultimately, this company can provide services that could affect the lives of more than three-quarters of the earth's population. Last March, just prior to the announcement of the Chartis agreement, I attended the Health Technology Investment Forum in San Francisco, where I predicted that the Company would add membership growth to our MyMedicalRecords Personal Health Record (PHR) and MyEsafeDepositBox services in excess of one million members over the course of a year."

Shareholder A: "Bob, you issued a press release recently stating you had retained The MichaelBass Group to identify potential strategic alliances. I recall you used acquisitions to help build a previous company. How is that progressing?"

Lorsch: "The MichaelBass Group is tasked with identifying opportunities. They maintain a database of hundreds of companies in the healthcare vertical with complementary technologies to our products and services. These are products that MMR will want to add to its product portfolio. They include those related to provisioning of lab reports, tools to deposit transcriptions to our health IT products, enhanced imaging report products, Bluetooth® patient monitoring devices, and comprehensive EMR services. It's faster to get to market and less expensive for us to acquire and integrate services than to build them ourselves. Our balance sheet and share price over the last six months continue to improve, thus allowing us to potentially use equity for Merger and Acquisition opportunities that fit our growth strategy and bring revenue to the Company."

Shareholder B: "Mr. Lorsch, isn't there a lot of competition for MMR's Personal Health Records. How do you intend to win against much larger companies with deeper pockets?"

Lorsch: "It's true that there is competition, however, there always is when you have a good idea. And MMR is a great product concept. Google Health is a name you're familiar with. We link to them, and we now understand they are phasing out of the personal health record market because they have not made it work. We think it's because integration is costly and the service is limited to the user accessing information from integrated partners. MMR's service is the opposite in that anyone can set up an account in minutes and receive medical records from any healthcare professional anywhere in the world. Microsoft HealthVault is making their network work, however, it really is not a direct product competitor as it also requires integration to healthcare providers to get benefit. In fact, within a year we plan on linking to HealthVault as well. However, Microsoft's products are more complex for the average user to access, while ours is easy and intuitive. Many companies have come and gone, but MMR is still here and continuing to expand users, products and services."

- more -

Shareholder C: "Bob, can you tell me what the Company is doing with its biotech assets. Can MMR make money from them?"

Lorsch: "Clearly, our plan is to monetize them. We have a powerful Board of Advisors assisting us with this, including Fred Middleton, Managing Director of Sanderling Ventures, and Ivor Royston, M.D., Founding Managing Member of Forward Ventures and a co-founder of IDEC Pharmaceuticals (now Biogen Idec). Sanderling and Forward Ventures together previously were the largest investors in Favrille, Inc., the predecessor public company to MMR, which raised more than $150 million from investors to fund its clinical efforts to develop a cancer vaccine to treat lymphomas. Those two funds alone invested more than $50 million in Favrille and, therefore, there is a rather significant interest in helping us recover those funds with these assets. Our anti-CD20 monoclonal antibodies as well as data, tissue samples and other technologies from the Company's Specifid vaccine trials and manufacturing processes work similar to Provenge from Dendreon, a company that has emerged from the lab to be a multi-billion dollar drug company based on recent FDA approvals of Provenge. Their drug targets prostate cancer patients in a similar way to our vaccine trials intended to target lymphoma. It uses the body's own immune system to target and attack cancer cells. We are spending considerable funds to resurrect patents and related Intellectual Property around the world and we are actively pursuing relationships to utilize these assets through independent consultants."

Shareholder D: "Bob, I see Hector Barreto on the dais with you. I know he's on the Company's Board of Directors. How is he helping to raise the visibility of the Company with the Latino business community?"

Lorsch: "You may recall I was in Washington D.C. last month, where I introduced Kodak, our strategic partner, to the group that Hector heads, The Latino Coalition. It's the largest group of Latino business people in the United States. In a recent presentation Hector pointed out that the Latino market is approaching one trillion dollars, and we will continue to work on selling our products into that market with Kodak and the support of The Coalition."

Shareholder E: "Mr. Lorsch, when can we expect to get projections from the Chartis, China, and MMRPro installations? Can you give us any guidance?"

Lorsch: "As you are aware, we have taken a very cautious approach to guidance. However, that said, we plan on giving guidance to the market limited to revenues prior to the end of this quarter. Meanwhile, because we are expanding rapidly, we are adding personnel, equipment and technology to support our growth. In fact, we recently completed recruiting a specialist in worldwide telecommunications who will be responsible for expanding the Company's worldwide network which we will soon be announcing. He will be helping us set up seamless communications for what we expect will be many millions of members from all over the world. I'll also ask Doug Helm, our board member who is supporting the Chartis relationship, to address your question with regard to Chartis."

Helm: "Thanks, Bob. I've flown 40,000 miles in the last couple of months, meeting with Chartis in places as far away as South Africa. Bob and I have spent weeks with them on training to get the program underway. There are lots of things happening between our companies in many of their markets around the world. Translation and in-country legal approvals take time. However, once things get going they stay going on auto-pilot. Chartis is a long term agreement and therefore we look forward to a long term worldwide relationship with Chartis."

About MMRGlobal, Inc.
MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports,

- more -

insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrvideos.com.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue." MMR Information Systems, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMR Information Systems, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMR Information Systems, Inc.'s business prospects, results of operations or financial condition, government regulation, and such other risks and uncertainties as detailed from time to time in MMR Information Systems, Inc.'s public filings with the U.S. Securities and Exchange Commission.

###

CONTACT:

Bobbie Volman
MMRGlobal, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com

Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz